Salarius Pharmaceuticals Inc (NAS:SLRX)
$ 1.54 0.09 (6.21%) Market Cap: 2.22 Mil Enterprise Value: -2.17 Mil PE Ratio: 0 PB Ratio: 0.42 GF Score: 31/100

Q3 2021 Salarius Pharmaceuticals Inc Earnings Call Transcript

Nov 04, 2021 / 09:00PM GMT
Release Date Price: $167.02 (-1.14%)
Operator

Thank you for standing by, and welcome to the Salarius Pharmaceuticals' Third Quarter 2021 Corporate and Financial Results Conference Call. (Operator Instructions)

And I would now like to hand the conference over to Jason Rando of Tiberend Strategic Advisors. Please go ahead.

Jason Rando
Tiberend Strategic Advisors, Inc. - EVP and COO

Good afternoon, and thank you for joining Salarius Pharmaceuticals' 2021 third quarter financial and corporate results call. Earlier this afternoon, Salarius Pharmaceuticals issued a press release detailing its financial results for the three months ended September 30, 2021, which we encourage listeners to read. The press release can be found in the News section of salariuspharma.com.

Before beginning today's call, I would like to make the following statement. Today we will be making certain forward-looking statements about operating metrics, future expectations, plans, events and circumstances, including statements about our strategy, future operations and the development and effectiveness of our lead

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot